Fingerprint
Dive into the research topics of 'Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically